UK-14,304
Test Ligands Values Explained
- Test Ligand ID - A unique identifier for the test ligand
 - Ligand Name - Name of the test ligand
 
| Test Ligand ID | 1943 | 
|---|---|
| Ligand Name | UK-14,304 | 
| PubMed Compound Id | 2435 | 
| Structure | |
| Molecular Formula | C11H10BrN5 | 
| Molecular Weight | 292.13 | 
| SMILES | C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br | 
| Synonyms | brimonidine 59803-98-4 Bromoxidine 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine UK-14304 brimonidina brimonidinum 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline E6GNX3HHTE NSC-318825 CHEBI:3175 DTXSID3045221 AGN-190342 FREE BASE UK-1430418 FREE BASE DTXCID1025221 Brimodine RefChem:58237 D11AX21 S01EA05 UK 14,304 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- MFCD00153878 C11H10BrN5 AGN 190342 MLS000069370 UK 14304 CHEMBL844 SMR000058355 Brimonidine (INN) NCGC00016069-09 UK 14304;AGN190342 BRIMONIDINE [INN] UK 14304 (tartrate);AGN190342 (tartrate) 5-Bromo-N-(2-imidazolin-2-yl)-6-quinoxalinamine Brimonidine [INN:BAN] CAS-59803-98-4 SR-01000000023 UNII-E6GNX3HHTE BRN 0751629 LK 14304-18 Brimonidine (Standard) Tocris-0425 [3H]-UK14304 Opera_ID_612 Lopac-U-104 BRIMONIDINE [MI] brimonidine (UK14304) BRIMONIDINE [VANDF] cid_2435 Lopac0_001216 SCHEMBL24670 BRIMONIDINE [WHO-DD] GTPL520 MLS001076349 BIDD:GT0649 SCHEMBL275296 GTPL5386 orb1306736 SCHEMBL29374525 BDBM34572 HY-B0659R [3H]brimonidine (UK14304) XYLJNLCSTIOKRM-UHFFFAOYSA-N HMS3259P09 HMS3263D14 HMS3266O03 HMS3411K05 HMS3675K05 HMS3887K07 HMS5086B09 BCP12632 EX-A5415 HY-B0659 MSK10706 Tox21_110299 Tox21_501216 AC-162 NSC318825 PDSP1_000640 PDSP2_000635 s9508 SBB080815 AKOS005267239 Brimonidine;AGN190342;UK14304 Tox21_110299_1 CCG-205290 DB00484 FB19008 GS-3236 LP01216 NC00638 NSC 318825 SDCCGSBI-0051183.P002 UK14304 MRF-0000657 NCGC00016069-01 NCGC00016069-02 NCGC00016069-03 NCGC00016069-04 NCGC00016069-05 NCGC00016069-06 NCGC00016069-07 NCGC00016069-08 NCGC00016069-10 NCGC00016069-11 NCGC00016069-12 NCGC00016069-13 NCGC00016069-24 NCGC00023468-02 NCGC00023468-04 NCGC00023468-05 NCGC00023468-06 NCGC00023468-07 NCGC00261901-01 SY053060 UK14,304 Brimonidine 100 microg/mL in Acetonitrile B4132 EU-0101216 NS00006954 EN300-50880 UK 14304-18 C07886 C75796 D07540 5-bromo-6-(2-imidazolidinylidenamino)quinoxaline 5-bromo-6-(2-imidazolin-2-ylamino) quinoxaline 5-Bromo-6-(2-imidazolin-2-ylamino)-quinoxaline 6-Quinoxalinamine,5-dihydro-1H-imidazol-2-yl)- (5-bromoquinoxalin-6-yl)-2-imidazolin-2-ylamine 803B984 A832477 L000615 Q577377 SR-01000000023-2 SR-01000000023-4 BRD-K68264559-001-10-0 BRD-K68264559-001-13-4 BRD-K68264559-045-02-4 BRD-K68264559-045-03-2 BRD-K68264559-045-04-0 5-Bromo-N-(4,5-dihydro-2-imidazolyl)quinoxalin-6-amine Z608061562 (5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine 5-bromanyl-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine 6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- (9CI) 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine;5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline  | 
| Created At | Jan 13, 2025 2:47 pm | 
| Updated At | Jan 13, 2025 2:47 pm |